ECOdrug: A database connecting drugs and conservation of their targets across species

Nucleic Acids Research

Volumn 46, Issue D1, 2018, Pages D930-D936

  Verbruggen, Bas ^a   Gunnarsson, Lina ^a   Kristiansson, Erik ^b   Österlund, Tobias ^b   Owen, Stewart F ^c   Snape, Jason R ^c,d   Tyler, Charles R ^a  

^a UNIVERSITY OF EXETER   (United Kingdom)

^b CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^c Global Environment   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; DEXLANSOPRAZOLE; ESOMEPRAZOLE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MEVINOLIN; OMEPRAZOLE; ROSUVASTATIN; ANTINEOPLASTIC AGENT; RNA; TUMOR PROTEIN;

ACCURACY; ARTICLE; CHLAMYDOMONAS REINHARDTII; CHOLESTEROL SYNTHESIS; DAPHNIA; DATA ANALYSIS; DRUG DATABASE; DRUG EFFICACY; DRUG INFORMATION; DRUG RESEARCH; DRUG SAFETY; DRUG SCREENING; DRUG TARGETING; INFORMATION PROCESSING; INFORMATION RETRIEVAL; LEMNA GIBBA; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN TARGETING; RELIABILITY; TOXICITY TESTING; AMINO ACID SEQUENCE; ANIMAL; ANTAGONISTS AND INHIBITORS; CHEMISTRY; COMPUTER INTERFACE; CONSERVED SEQUENCE; DRUG DELIVERY SYSTEM; DRUG DEVELOPMENT; ENVIRONMENTAL PROTECTION; FISH; FORECASTING; GENETICS; HUMAN; INVERTEBRATE; MAMMAL; MOLECULARLY TARGETED THERAPY; NEOPLASM; PRECLINICAL STUDY; RISK ASSESSMENT; SPECIES DIFFERENCE;

AMINO ACID SEQUENCE; ANIMALS; ANTINEOPLASTIC AGENTS; CONSERVATION OF NATURAL RESOURCES; CONSERVED SEQUENCE; DATA COLLECTION; DATA DISPLAY; DATABASES, PHARMACEUTICAL; DRUG DELIVERY SYSTEMS; DRUG DISCOVERY; DRUG EVALUATION, PRECLINICAL; FISHES; FORECASTING; HUMANS; INVERTEBRATES; MAMMALS; MOLECULAR TARGETED THERAPY; NEOPLASM PROTEINS; NEOPLASMS; RISK ASSESSMENT; RNA, NEOPLASM; SPECIES SPECIFICITY; USER-COMPUTER INTERFACE;

EID: 85040919672     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkx1024     Document Type: Article

References (34)

1. Boxall, A.B.A., Rudd, M.A., Brooks, B.W., Caldwell, D.J., Choi, K., Hickmann, S., Innes, E., Ostapyk, K., Staveley, J.P., Verslycke, T., et al. (2012) Pharmaceuticals and personal care products in the environment: What are the big questions Environ. Health Perspect., 120, 1221-1229.
2. Desbrow, C., Routledge, E.J., Brighty, G.C., Sumpter, J.P., Waldock, M. (1998) Identification of Estrogenic Chemicals in STW Effluent. 1. Chemical Fractionation and in Vitro Biological Screening. Environ. Sci. Technol., 32, 1549-1558.
3. Ausder Beek, T., Weber, F.-A., Bergmann, A., Hickmann, S., Ebert, I., Hein, A., Kuster, A. (2016) Pharmaceuticals in the environment-global occurrences and perspectives. Environ. Toxicol. Chem., 35, 823-835.
4. Winter, M.J., Redfern, W.S., Hayfield, A.J., Owen, S.F., Valentin, J.P., Hutchinson, T.H. (2008) Validation of a larval zebrafish locomotor assay for assessing the seizure liability of early-stage development drugs. J. Pharmacol. Toxicol. Methods, 57, 176-187.
5. Parker, T., Libourel, P.A., Hetheridge, M.J., Cumming, R.I., Sutcliffe, T.P., Goonesinghe, A.C., Ball, J.S., Owen, S.F., Chomis, Y., Winter, M.J. (2014) A multi-endpoint in vivo larval zebrafish (Danio rerio) model for the assessment of integrated cardiovascular function. J. Pharmacol. Toxicol. Methods, 69, 30-38.
6. Zhang, C., Ball, J., Panzica-Kelly, J., Augustine-Rauch, K. (2016) In vitro developmental toxicology screens: A report on the progress of the methodology and future applications. Chem. Res. Toxicol., 29, 534-544.
7. European Medicines Agency (2006) Guideline on the environmental risk assessment of medicinal products for human use. EMEA/CHMP/SWP/4447/00 corr, 2, 4-12.
8. U.S. Department of Health and Human Services Food and Drug Administration (1998) Guidance for industry. Environmental assessment of human drug and biologics applications. CMC 6, 1-27.
9. Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A.C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., et al. (2014) DrugBank 4.0: Shedding new light on drug metabolism. Nucleic Acids Res., 42, D1091-D1097.
10. Santos, R., Ursu, O., Gaulton, A., Bento, A.P., Donadi, R.S., Bologa, C.G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T.I., et al. (2017) A comprehensive map of molecular drug targets. Nat. Rev. Drug Discov., 16, 19-34.
11. Bento, A.P., Gaulton, A., Hersey, A., Bellis, L.J., Chambers, J., Davies, M., Kr üger, F.A., Light, Y., Mak, L., McGlinchey, S., et al. (2014) The ChEMBL bioactivity database: An update. Nucleic Acids Res., 42, D1083-D1090.
12. LaLone, C.A., Villeneuve, D.L., Lyons, D., Helgen, H.W., Robinson, S.L., Swintek, J.A., Saari, T.W., Ankley, G.T. (2016) Editor's highlight: Sequence alignment to predict across species susceptibility (SeqAPASS): A web-based tool for addressing the challenges of cross-species extrapolation of chemical toxicity. Toxicol. Sci., 153, 228-245.
13. Gabaldon, T., Koonin, E.V. (2013) Functional and evolutionary implications of gene orthology. Nat. Rev. Genet., 14, 360-366.
14. Kristensen, D.M., Wolf, Y.I., Mushegian, A.R., Koonin, E.V. (2011) Computational methods for Gene Orthology inference. Brief. Bioinform., 12, 379-391.
15. Kriventseva, E.V., Tegenfeldt, F., Petty, T.J., Waterhouse, R.M., Simaõ, F.A., Pozdnyakov, I.A., Ioannidis, P., Zdobnov, E.M. (2015) OrthoDB v8: Update of the hierarchical catalog of orthologs and the underlying free software. Nucleic Acids Res., 43, D250-D256.
16. Altenhoff, A.M., Boeckmann, B., Capella-Gutierrez, S., Dalquen, D.A., DeLuca, T., Forslund, K., Huerta-Cepas, J., Linard, B., Pereira, C., Pryszcz, L.P. (2016) Standardized benchmarking in the quest for orthologs. Nat. Methods, 13, 425-430.
17. Maher, M.C., Hernandez, R.D. (2015) Rock, paper, scissors: Harnessing complementarity in ortholog detection methods improves comparative genomic inference. G3, 5, 629-638.
18. Pryszcz, L.P., Huerta-Cepas, J., Gabaldón, T. (2010) MetaPhOrs: Orthology and paralogy predictions from multiple phylogenetic evidence using a consistency-based confidence score. Nucleic Acids Res., 39, e32.
19. Herrero, J., Muffato, M., Beal, K., Fitzgerald, S., Gordon, L., Pignatelli, M., Vilella, A.J., Searle, S.M., Amode, R., Brent, S. (2016) Ensembl comparative genomics resources. Database, 2016, bav096.
20. Huerta-Cepas, J., Szklarczyk, D., Forslund, K., Cook, H., Heller, D., Walter, M.C., Rattei, T., Mende, D.R., Sunagawa, S., Kuhn, M. (2015) eggNOG 4.5: A hierarchical orthology framework with improved functional annotations for eukaryotic, prokaryotic and viral sequences. Nucleic Acids Res., 44, D296-D293.
21. Sonnhammer, E.L., Ö stlund, G. (2015) InParanoid 8: Orthology analysis between 273 proteomes, mostly eukaryotic. Nucleic Acids Res., 43, D234-D239.
22. Durinck, S., Spellman, P., Birney, E., Huber, W. (2009) Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt. Nat. Protoc., 4, 1184-1191.
23. WHO CollaboratingCentre for Drug Statistics Methodology (2013) Guidelines for ATC classification and DDD assignment 2013. WHO. Oslo, https://www.whocc.no/filearchive/publications/1 2013guidelines.pdf.
24. The UniProt Consortium (2017) UniProt: The universal protein knowledgebase. Nucleic Acids Res., 45, D158-D169.
25. Kersey, P.J., Lawson, D., Birney, E., Derwent, P.S., Haimel, M., Herrero, J., Keenan, S., Kerhornou, A., Koscielny, G., Kähäri, A. (2010) Ensembl Genomes: Extending Ensembl across the taxonomic space. Nucleic Acids Res., 38, D563-D569.
26. McWilliam, H., Li, W., Uludag, M., Squizzato, S., Park, Y.M., Buso, N., Cowley, A.P., Lopez, R. (2013) Analysis tool web services from the EMBL-EBI. Nucleic Acids Res., 41, W597-W600.
27. Gunnarsson, L., Jauhiainen, A., Kristiansson, E., Nerman, O., Larsson, D.G.J. (2008) Evolutionary conservation of human drug targets in organisms used for environmental risk assessments. Environ. Sci. Technol., 42, 5807-5813.
28. Castro, L.F.C., Goncąlves, O., Mazan, S., Tay, B.-H., Venkatesh, B., Wilson, J.M. (2014) Recurrent gene loss correlates with the evolution of stomach phenotypes in gnathostome history. Proc. R. Soc. B Biol. Sci., 281, 20132669.
29. Holzer, G., Roux, N., Laudet, V. (2017) Evolution of ligands, receptors and metabolizing enzymes of thyroid signaling. Mol. Cell. Endocrinol., doi:10.1016/j.mce.2017.03.021.
30. Pacini, F., Castagna, M.G., Brilli, L., Pentheroudakis, G. (2012) Thyroid cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann. Oncol, 23(Suppl. 7), vii110-vii119.
31. Friesen, J.A., Rodwell, V.W. (2004) The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases. Genome Biol., 5, 248-248.
32. Li, W., Liu, W., Wei, H., He, Q., Chen, J., Zhang, B., Zhu, S. (2014) Species-specific expansion and molecular evolution of the 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGR) gene family in plants. PLOS One, 9, e94172.
33. Vestel, J., Caldwell, D.J., Constantine, L., D'Aco, V.J., Davidson, T., Dolan, D.G., Millard, S.P., Murray-Smith, R., Parke, N.J., Ryan, J.J., et al. (2016) Use of acute and chronic ecotoxicity data in environmental risk assessment of pharmaceuticals. Environ Toxicol. Chem., 35, 1201-1212.
34. Brain, R.A., Reitsma, T.S., Lissemore, L.I., Bestari, K., Sibley, P.K., Solomon, K.R. (2006) Herbicidal effects of statin pharmaceuticals in lemna gibba. Environ. Sci. Technol., 40, 5116-5123.